Delivery Order SPE2DB24D1205-SPE2DB24FCQTA
Award Date
4/23/24
Potential Completion Date
5/14/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $110,408.40 firm-fixed-price delivery order is for the supply of 4,565,683,425 units of the medication DARZALEX FASPRO 1,800MG-30,000 15ML. The contract has an ultimate completion date of September 25, 2024 and was awarded on September 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $11,040.84 firm fixed-price delivery order contract (SPE2DB22D3016|SPE2DB24FARH4) for the supply of DARZALEX FASPRO pharmaceutical products. This delivery order is under an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $55,204.20 firm-fixed-price delivery order is for the supply of 4,566,078,093 units of the prescription drug DARZALEX FASPRO, a 1,800mg/30,000 15mL vial. The contract has an ultimate completion date of November 1, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, is for the supply of 4,565,119,522 units of the pharmaceutical product DARZALEX FASPRO 1,800MG-30,000 15ML. The $17,481.48 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense, and has an ultimate completion date of August 1, 2024. This contract is not a set-aside award. Amerisourcebergen...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $165,612.60 contract is for the supply of 4,565,965,016 units of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty medication. The delivery order has an ultimate completion date of October 21, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The $55,204.20 Firm Fixed Price contract is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a prescription drug product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The contract, valued at $17,940.63, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which is valued at $999,999,999 and runs through November 2026. The contract provides for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $33,122.52 Delivery Order is for the provision of 4,564,490,081 units of the pharmaceutical product DARZALEX FASPRO 1,800MG-30,000 15ML. The contract has a firm fixed price, with a completion date of May 24, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the...
This federal contract award is for the delivery of DARZALEX FASPRO, a specialty pharmaceutical medication, to the Defense Logistics Agency (DLA). The $34,267.32 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 13, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
The U.S. Defense Logistics Agency (DLA) awarded a $35,881.26 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 30,000 units of the specialty drug DARZALEX FASPRO 1,800MG-30,000 15ML. The contract has an ultimate completion date of January 27, 2025 and was awarded on January 3, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...